Extrapancreatic Tumors in Intraductal Papillary Mucinous Neoplasm of the Pancreas.
10.4166/kjg.2009.54.3.162
- Author:
Seok Jin OH
1
;
Se Joon LEE
;
Hwal Youn LEE
;
Yong Han PAIK
;
Dong Ki LEE
;
Kwan Sik LEE
;
Jae Bock CHUNG
;
Jeong Sik YU
;
Dong Sup YOON
Author Information
1. Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea. leesj@yuhs.ac
- Publication Type:Original Article ; English Abstract
- Keywords:
Intraductal papillary mucinous neoplasm (IPMN);
Pancreas;
Extrapancreatic tumors
- MeSH:
Adenocarcinoma, Mucinous/*diagnosis/pathology/ultrasonography;
Adult;
Aged;
Aged, 80 and over;
Carcinoma, Pancreatic Ductal/*diagnosis/pathology/ultrasonography;
Carcinoma, Papillary/*diagnosis/pathology/ultrasonography;
Female;
Humans;
Incidence;
Male;
Middle Aged;
Neoplasms, Multiple Primary/diagnosis/*epidemiology;
Neoplasms, Second Primary/diagnosis/*epidemiology;
Pancreatectomy;
Pancreatic Neoplasms/*diagnosis/pathology/ultrasonography;
Retrospective Studies;
Tomography, X-Ray Computed
- From:The Korean Journal of Gastroenterology
2009;54(3):162-166
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: Intraductal papillary mucinous neoplasm (IPMN) of the pancreas has a favorable prognosis, but seems to be associated with a high incidence of extrapancreatic tumors. The purpose of this study was to evaluate the incidence and clinicopathological features of extrapancreatic tumors associated with IPMN. METHODS: Thirty-seven patients with IPMN of the pancreas, confirmed by surgical resection and typical findings of endoscopic ultrasonography and CT imaging between October 1, 1998 and August 31, 2006 were included. Seventeen patients were diagnosed with surgical resection and biopsy, and others by typical imaging findings of IPMN. These patients were examined for the development of extrapancreatic tumors. RESULTS: Of 37 patients with IPMN, 14 (38%) had 18 extrapancreatic tumors, and 10 (27%) had 13 extrapancreatic malignancies. Five, six, and two extrapancreatic malignancies had diagnosed before during, and after the diagnosis of IPMN. Gastric adenocarcinoma (3 patients, 23%) and colorectal carcinoma (3 patients, 23%) were the most common neoplasms. Other extrapancreatic tumors included lung cancer (n=2), prostatic cancer (n=1), renal cell carcinoma (n=1), cholangiocelluar carcinoma (n=1), urinary bladder cancer (n=1), and gallbladder cancer (n=1), respectively. As benign tumor, there were two gallbladder adenoma, one gastric adenoma, one colonic adenoma and one benign ovarian cystic neoplasm, respectively. CONCLUSIONS: IPMN is associated with high incidence of extrapancreatic tumors, particularly gastric and colorectal neoplasms. Upper gastrointestinal endoscopy and colonoscopy should be done, and systemic surveillance for the possible occurrence of other tumors may allow early detection of extrapancreatic tumor in patients with IPMN.
